PT1670803E - Certas lactamas espirocíclicas substituídas e a sua utilização como produtos farmacêuticos - Google Patents
Certas lactamas espirocíclicas substituídas e a sua utilização como produtos farmacêuticos Download PDFInfo
- Publication number
- PT1670803E PT1670803E PT04765790T PT04765790T PT1670803E PT 1670803 E PT1670803 E PT 1670803E PT 04765790 T PT04765790 T PT 04765790T PT 04765790 T PT04765790 T PT 04765790T PT 1670803 E PT1670803 E PT 1670803E
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceuticals
- certain substituted
- substituted spirocyclic
- spirocyclic lactams
- lactams
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323204.8A GB0323204D0 (en) | 2003-10-03 | 2003-10-03 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1670803E true PT1670803E (pt) | 2008-04-23 |
Family
ID=29415468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04765790T PT1670803E (pt) | 2003-10-03 | 2004-10-04 | Certas lactamas espirocíclicas substituídas e a sua utilização como produtos farmacêuticos |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20070015781A1 (pt) |
| EP (1) | EP1670803B1 (pt) |
| JP (1) | JP4549350B2 (pt) |
| CN (1) | CN1863804B (pt) |
| AT (1) | ATE388954T1 (pt) |
| AU (1) | AU2004279553C1 (pt) |
| BR (1) | BRPI0415015A (pt) |
| CA (1) | CA2540249A1 (pt) |
| DE (1) | DE602004012426T2 (pt) |
| ES (1) | ES2300815T3 (pt) |
| GB (1) | GB0323204D0 (pt) |
| HK (1) | HK1092472A1 (pt) |
| MX (1) | MXPA06003645A (pt) |
| PL (1) | PL1670803T3 (pt) |
| PT (1) | PT1670803E (pt) |
| WO (1) | WO2005035535A1 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1565428A1 (en) * | 2002-11-27 | 2005-08-24 | Elan Pharmaceuticals, Inc. | Substituted ureas and carbamates |
| CN101193892A (zh) * | 2005-06-14 | 2008-06-04 | 先灵公司 | 大环杂环天冬氨酰基蛋白酶抑制剂 |
| ATE550338T1 (de) * | 2005-07-18 | 2012-04-15 | Merck Sharp & Dohme | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit |
| US7745484B2 (en) * | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| MX2011003015A (es) | 2008-09-18 | 2011-11-18 | Univ Northwestern | Moduladores del receptor de n-metil-d-aspartato, y usos de los mismos. |
| GB201122113D0 (en) | 2011-12-22 | 2012-02-01 | Convergence Pharmaceuticals | Novel compounds |
| MX2015009773A (es) | 2013-01-29 | 2016-08-05 | Aptinyx Inc | Moduladores de receptores nmda de espiro-lactama y sus usos. |
| ES2935352T3 (es) | 2013-01-29 | 2023-03-06 | Aptinyx Inc | Moduladores de receptores NMDA de espiro-lactama y sus usos |
| WO2014120800A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| KR102410989B1 (ko) | 2013-01-29 | 2022-06-17 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조절인자 및 그의 용도 |
| BR112015018095A2 (pt) | 2013-01-29 | 2017-07-18 | Naurex Inc | moduladores de receptor nmda de espiro-lactama e usos dos mesmos |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| WO2017201283A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| ES2973283T3 (es) | 2016-08-01 | 2024-06-19 | Tenacia Biotechnology Hong Kong Co Ltd | Moduladores de receptores de NMDA espirolactámicos y usos de los mismos |
| CA3031534C (en) | 2016-08-01 | 2023-10-17 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| AU2017306164B2 (en) | 2016-08-01 | 2021-10-21 | Aptinyx Inc. | Spiro-lactam NMDA modulators and methods of using same |
| BR112019001768A2 (pt) | 2016-08-01 | 2019-06-11 | Aptinyx Inc | moduladores do receptor de spiro-lactamas nmda e usos dos mesmos |
| CN109661398B (zh) | 2016-08-01 | 2022-07-05 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺和二-螺-内酰胺nmda受体调节剂及其用途 |
| WO2019152687A1 (en) | 2018-01-31 | 2019-08-08 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
| WO2024092043A1 (en) * | 2022-10-26 | 2024-05-02 | Protego Biopharma, Inc. | Spirocycle containing pyridine compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534520A (en) | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| DE69900220T2 (de) * | 1998-06-12 | 2002-05-08 | Hoffmann La Roche | Diaza-spiro[3,5]nonan-Derivate |
| US6613764B1 (en) * | 1999-01-06 | 2003-09-02 | The United States Of America As Represented By The Department Of Health And Human Services | Aspartic protease inhibitors |
| AU2002256418A1 (en) * | 2001-04-27 | 2002-11-11 | Vertex Pharmaceuticals Incorporated | Inhibitors of bace |
| KR20070094802A (ko) * | 2004-12-20 | 2007-09-21 | 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. | ＭｙＤ８８ 동종이량체화 억제제 |
-
2003
- 2003-10-03 GB GBGB0323204.8A patent/GB0323204D0/en not_active Ceased
-
2004
- 2004-10-04 BR BRPI0415015-5A patent/BRPI0415015A/pt not_active IP Right Cessation
- 2004-10-04 WO PCT/EP2004/011054 patent/WO2005035535A1/en active IP Right Grant
- 2004-10-04 PT PT04765790T patent/PT1670803E/pt unknown
- 2004-10-04 CA CA002540249A patent/CA2540249A1/en not_active Abandoned
- 2004-10-04 CN CN2004800288403A patent/CN1863804B/zh not_active Expired - Fee Related
- 2004-10-04 AU AU2004279553A patent/AU2004279553C1/en not_active Ceased
- 2004-10-04 AT AT04765790T patent/ATE388954T1/de not_active IP Right Cessation
- 2004-10-04 MX MXPA06003645A patent/MXPA06003645A/es active IP Right Grant
- 2004-10-04 JP JP2006530082A patent/JP4549350B2/ja not_active Expired - Fee Related
- 2004-10-04 PL PL04765790T patent/PL1670803T3/pl unknown
- 2004-10-04 EP EP04765790A patent/EP1670803B1/en not_active Not-in-force
- 2004-10-04 ES ES04765790T patent/ES2300815T3/es active Active
- 2004-10-04 US US10/574,536 patent/US20070015781A1/en not_active Abandoned
- 2004-10-04 DE DE602004012426T patent/DE602004012426T2/de active Active
-
2006
- 2006-11-29 HK HK06113107A patent/HK1092472A1/xx not_active IP Right Cessation
-
2007
- 2007-06-26 US US11/823,311 patent/US7655686B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7655686B2 (en) | 2010-02-02 |
| CA2540249A1 (en) | 2005-04-21 |
| CN1863804B (zh) | 2010-05-26 |
| US20070265328A1 (en) | 2007-11-15 |
| EP1670803A1 (en) | 2006-06-21 |
| JP4549350B2 (ja) | 2010-09-22 |
| DE602004012426T2 (de) | 2009-03-26 |
| GB0323204D0 (en) | 2003-11-05 |
| HK1092472A1 (en) | 2007-02-09 |
| BRPI0415015A (pt) | 2006-11-07 |
| AU2004279553C1 (en) | 2009-07-23 |
| AU2004279553B2 (en) | 2009-03-12 |
| ES2300815T3 (es) | 2008-06-16 |
| US20070015781A1 (en) | 2007-01-18 |
| CN1863804A (zh) | 2006-11-15 |
| MXPA06003645A (es) | 2006-06-05 |
| ATE388954T1 (de) | 2008-03-15 |
| PL1670803T3 (pl) | 2008-08-29 |
| DE602004012426D1 (de) | 2008-04-24 |
| JP2007509038A (ja) | 2007-04-12 |
| WO2005035535A1 (en) | 2005-04-21 |
| EP1670803B1 (en) | 2008-03-12 |
| AU2004279553A1 (en) | 2005-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1092472A1 (en) | Certain substituted spirocyclic lactams and use thereof as pharmaceuticals | |
| GEP20084329B (en) | 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension | |
| MXPA05010137A (es) | Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina. | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| NO20063355L (no) | Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet | |
| MY136520A (en) | Novel compounds | |
| WO2005123731A3 (en) | Pyrrolopyridine derivatives and their use as crth2 antagonists | |
| WO2006034039A3 (en) | Substituted morphinans and methods of their use | |
| TW200833670A (en) | Novel compounds 569 | |
| SI1730144T1 (sl) | Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on | |
| TW200740781A (en) | Novel compounds | |
| DE602004024213D1 (en) | Aminopropanolderivate | |
| WO2005040171A8 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
| IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
| SI1673354T1 (sl) | Arilindenopiridini in arilindenopirimidini in njihova uporaba kot antagonisti adenozinskih A2a-receptorjev | |
| WO2005000840A8 (en) | Substituted diketopiperazines and their use as oxytocin antagonists | |
| MXPA05011163A (es) | Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides. | |
| MXPA02012426A (es) | Compuestos nuevos. | |
| TW200504059A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
| WO2003045940A3 (en) | Benzazepine derivatives and their use as 5-ht ligands | |
| TNSN06410A1 (en) | Pyrrolopyridine derivatives and their use as crth2 antagonists | |
| MXPA05005340A (es) | Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen. |